Sparkle of Hope Gala Chair
Sparkle of Hope Gala Chair
TAREK RABAH Chief Executive Officer Otsuka America, Inc.
BRENT RAGANS President Ferring Holding Inc. (US)
Throughout his career, Tarek has brought together high- functioning teams that challenge conventional thinking and deliver results in complex, challenging business environments. His commitment to empowering and supporting those around him has unlocked innovation and directly impacted the lives of patients. As a citizen of the world, Tarek brings an intuitive global perspective that infuses diversity, transparency, and performance accountability as key tenets in his business philosophy. Tarek is a growth-oriented executive with extensive experience leading large, multifaceted commercial organizations. In his more than 20 years of experience, he has successfully launched brands and led divisions with AstraZeneca and Novartis in the United States, Europe, South America, Japan, and the Middle East. His expertise spans therapeutic areas in highly competitive and complex healthcare categories. For Tarek, leadership is not about having all the answers, rather it is about creating an environment where Otsuka-people are deeply connected to their purpose, and the people they serve. Tarek joined Otsuka in 2022 as President & CEO of Otsuka’s North America Pharmaceutical Business, with responsibility in the US and Canada. Driven by his personal passion to improve the lives of people, Tarek is leading Otsuka’s commercial organization efforts to introduce products, programs, policies, and advocacy initiatives that help address unmet medical needs and untapped market opportunities. He holds a BS in Biology and a BA in Business from the American University of Beirut, and an MBA from McGill University. He is fluent in five languages. “We truly work to change lives at Otsuka—I am continuously inspired by Otsuka-people to uncover new ways to advance innovative health solutions, and for the opportunity to make an impact in the lives of those we serve.”
Brent Ragans is the U.S. President of Ferring Pharmaceuticals, a privately-owned, biopharma company that focuses on developing life-changing innovations that help people live better lives. In the United States, Ferring is a leader in reproductive medicine, uro-oncology and in specialty areas within orthopaedics, and gastroenterology, including microbiome therapeutics.
Brent’s vision for serving patients is grounded in Ferring’s 70-year commitment to science, research and the relentless pursuit of therapies that help people build families, stay healthy and fight disease. Becoming president in June 2020, Brent focused Ferring U.S. in the therapy areas where it makes the greatest positive differences for patients. Previously as U.S. Chief Commercial Officer, Brent led commercial strategy and operations as the company introduced new products and doubled its sales. Brent has extensive experience in the pharmaceutical industry, including leading multiple units and teams in both prescription pharmaceuticals and consumer OTC. Before joining Ferring in 2012, he built and led several multibillion-dollar brands for Sanofi, where his last position was Senior Vice President of North American Consumer Healthcare Strategy and Corporate Development. Brent began his career at Bock Pharmaceuticals. Brent holds a Bachelor of Science degree in Legal Communications and Marketing from Florida State University. Outside of Ferring, Brent contributes his efforts to supporting several philanthropic and educational causes. He sits on the Board of Directors for Community Hope and is a Co-Chair for their Sparkle of Hope Gala. Brent is also a Co-Chair of the SDHB PheoPara Coalition Gala. He is a member of the Healthcare Leadership Council based in Washington, DC. Brent is also an active participant in the mentorship program of Florida State University, where he also shares his experience and expertise as a business leader with MBA students as a guest lecturer.
Made with FlippingBook - Online Brochure Maker